Ambar Protein Industries Limited (BOM:519471)
India · Delayed Price · Currency is INR 185.00
-8.60 (-4.44%)
At close: Jun 1, 2026
Ambar Protein Industries Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Other Revenue | 0 | 0 | -0 | - | - | - |
| 4,817 | 4,216 | 3,372 | 3,451 | 3,397 | 3,133 | |
Revenue Growth (YoY) | 25.66% | 25.03% | -2.27% | 1.57% | 8.44% | 10.18% |
Cost of Revenue | 4,596 | 3,959 | 3,190 | 3,291 | 3,220 | 2,998 |
Gross Profit | 220.44 | 257.06 | 182.45 | 159.77 | 177.94 | 134.9 |
Selling, General & Admin | 32.01 | 27.34 | 22.43 | 21.99 | 26.68 | 13.28 |
Other Operating Expenses | 64.83 | 64.41 | 81.38 | 60.37 | 52.75 | 38.99 |
Operating Expenses | 109.08 | 104.86 | 116.94 | 95.11 | 92.24 | 64.28 |
Operating Income | 111.36 | 152.2 | 65.51 | 64.66 | 85.7 | 70.62 |
Interest Expense | -20.21 | -22.27 | -24.24 | -25.3 | -26.91 | -26.18 |
Interest & Investment Income | 0.79 | 0.79 | 0.24 | 0.15 | 0.27 | 0.4 |
Other Non Operating Income (Expenses) | -0.41 | -0.41 | -0.31 | 0.08 | - | -0.26 |
EBT Excluding Unusual Items | 91.53 | 130.31 | 41.2 | 39.59 | 59.07 | 44.58 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | -4.78 |
Pretax Income | 91.53 | 130.31 | 41.2 | 39.59 | 59.07 | 39.8 |
Income Tax Expense | 21.05 | 33.81 | 9.74 | 11.46 | 14.57 | 5.31 |
Net Income | 70.47 | 96.5 | 31.46 | 28.13 | 44.5 | 34.49 |
Net Income to Common | 70.47 | 96.5 | 31.46 | 28.13 | 44.5 | 34.49 |
Net Income Growth | 5.00% | 206.77% | 11.82% | -36.78% | 29.02% | 176.65% |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Change (YoY) | -0.42% | - | - | 0.01% | 0.02% | -0.02% |
EPS (Basic) | 12.26 | 16.78 | 5.47 | 4.89 | 7.74 | 6.00 |
EPS (Diluted) | 12.26 | 16.78 | 5.47 | 4.89 | 7.74 | 6.00 |
EPS Growth | 5.43% | 206.76% | 11.80% | -36.79% | 29.00% | 176.71% |
Free Cash Flow | - | 10.26 | 62.79 | 54.42 | -32.11 | 2.6 |
Free Cash Flow Per Share | - | 1.78 | 10.92 | 9.46 | -5.58 | 0.45 |
Gross Margin | 4.58% | 6.10% | 5.41% | 4.63% | 5.24% | 4.31% |
Operating Margin | 2.31% | 3.61% | 1.94% | 1.87% | 2.52% | 2.25% |
Profit Margin | 1.46% | 2.29% | 0.93% | 0.81% | 1.31% | 1.10% |
Free Cash Flow Margin | - | 0.24% | 1.86% | 1.58% | -0.95% | 0.08% |
EBITDA | 124.45 | 165.31 | 78.65 | 77.41 | 98.51 | 82.63 |
EBITDA Margin | 2.58% | 3.92% | 2.33% | 2.24% | 2.90% | 2.64% |
D&A For EBITDA | 13.09 | 13.11 | 13.14 | 12.75 | 12.81 | 12.01 |
EBIT | 111.36 | 152.2 | 65.51 | 64.66 | 85.7 | 70.62 |
EBIT Margin | 2.31% | 3.61% | 1.94% | 1.87% | 2.52% | 2.25% |
Effective Tax Rate | 23.00% | 25.95% | 23.64% | 28.94% | 24.66% | 13.34% |
Revenue as Reported | 4,824 | 4,225 | 3,377 | 3,456 | 3,404 | 3,138 |
Advertising Expenses | - | 10.23 | 8.81 | 7.87 | 13.07 | 1.95 |